Advertisement

AT III in Pregnancy and Newborn Infants

  • Hermann Erich Karges
Conference paper

Abstract

Blood fluidity is determined by the balance between the components of the coagulation and fibrinolytic pathways. The balance is maintained by the activators and inhibitors of the respective proenzymes and enzymes (Fig. 1). Disturbances in either of these systems lead to thrombosis or bleeding.

Keywords

Newborn Infant Normal Pregnancy Thrombotic Complication Acta Obstet Gynecol Blood Clotting System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gjønnaes H, Fagerhol MK (1975) Studies on coagulation and fibrinolysis in pregnancy. Acta Obstet Gynecol Scand 54: 363–367CrossRefGoogle Scholar
  2. 2.
    Ambrus JL, Ambrus CM, Lillie MA, Browne BJ, Hanson FW, Niswander K, Witul M, Jung DS, Bartfay-Szabo A (1976) Effects of various estrogen treatment schedules on antithrombin III levels. Commun Chemic Pathol Pharmacol 14: 543–549Google Scholar
  3. 3.
    Weiner CP, Brand Y (1980) Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 56: 603–610Google Scholar
  4. 4.
    Hellgren M, Blomäck M (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 13: 141 – 154CrossRefGoogle Scholar
  5. 5.
    Weenink GH, Treffers PE, Kahlé LH, ten Cate JW (1982) Antithrombin III in normal pregnancy. Thromb Res 26: 281–287PubMedCrossRefGoogle Scholar
  6. 6.
    Villesanta U (1965) Thromboembolic disease in pregnancy. Am J Obstet Gynecol 93: 142–160Google Scholar
  7. 7.
    Husni EA, Pena LI, Engle-Lenhert A (1967) Thrombophlebitis in pregnancy. Am J Obstet Gynecol 97: 901–905PubMedGoogle Scholar
  8. 8.
    Aaro LA, Juergens JC (1971) Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol 109: 1128–1136PubMedGoogle Scholar
  9. 9.
    Flessa HC, Glueck HI, Dritschilo A (1974) Thromboembolic disorders in pregnancy: pathophysiology, diagnosis, and treatment with emphasis on heparin. Clin Obstet Gynecol 17: 195–235PubMedCrossRefGoogle Scholar
  10. 10.
    Hillesma V (1960) Occurrence and anticoagulant treatment of thromboembolism in gravidas, parturients and gynecologic patients. Acta Obstet Gynecol Scand (Suppl 2) 39: 5–76CrossRefGoogle Scholar
  11. 11.
    Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW (1980) Severe antithrombin III deficiency in a patient with pre-eclampsia. Scand J Haematol 25: 81–86PubMedCrossRefGoogle Scholar
  12. 12.
    Hellgren M, Nygards E-B, Robbe H (1982) Antithrombin III in late pregnancy. Acta Obstet Gynecol Scand 61: 187–189PubMedCrossRefGoogle Scholar
  13. 13.
    Schregel W, Straub H, Wölk G, Schneider R (1984) Successful treatment of massive dissiminated intravascular coagulation in EPH gestosis with multiple organ insufficiency. Anasth Intensivther Notfallmed 19: 201–203PubMedCrossRefGoogle Scholar
  14. 14.
    Goubran, F, Fareed A, Elian A, Abolouz S (1985) Antithrombin III and α 2 -macroglobulin in normal pregnancy and preeclampsia. Thromb Haemost 54: 204Google Scholar
  15. 15.
    Friedman KD, Borok Z, Owen J (1986) Heparin cofactor activity and antithrombin III antigen levels in preeclampsia. Thromb Res 43: 409–416PubMedCrossRefGoogle Scholar
  16. 16.
    Brandt P (1981) Observations during the treatment of antithrombin III deficient women with heparin and antithrombin concentrate during pregnancy, parturation and abortion. Thromb Res 22: 15–24PubMedCrossRefGoogle Scholar
  17. 17.
    Handeland GF, Abildgaard U (1985) In vivo recovery of antithrombin concentrates. Thromb Res 39: 133–138PubMedCrossRefGoogle Scholar
  18. 18.
    Schoch U, Zanetti E, von Feiten A (1987) Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis. Schweiz Med Wochenschr 117: 1807–1810PubMedGoogle Scholar
  19. 19.
    De Stefano V, Leone G, de Carolis S, Ferelli R, di Donfrancesco A, Moneta E, Bizzi B (1988) Management of pregnancy in women with antithrombin III congenital defect: Report of four cases. Thromb Haemost 59: 193–196PubMedGoogle Scholar
  20. 20.
    Jürgens H, Göbel U, Bokelmann J, von Voss H, Wahn V (1979) Coagulation studies on umbilical arterial and venous blood from normal newborn babies. Eur J Pediatr 131: 199–204PubMedCrossRefGoogle Scholar
  21. 21.
    Peters M, Breederveld C, Kahlé LH, ten Cate JW (1982) Rapid microanalysis of coagulation parameters by automated chromogenic substrate methods — application in neonatal patients. Thromb Res 28: 773–781PubMedCrossRefGoogle Scholar
  22. 22.
    Peters M, ten Cate JW, Koo LH, Breederveld C (1984) Persistent antithrombin III deficiency: Risk factor for thromboembolic complications in neonates small for gestational age. J Pediatr 105: 310–314PubMedCrossRefGoogle Scholar
  23. 23.
    Andrew M, Pars B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70: 165–172PubMedGoogle Scholar
  24. 24.
    McDonald MM, Hathaway WE, Reeve EB, Leonard BD (1982) Biochemical and functional study of antithrombin III in newborn infants. Thromb Haemost 47: 56–58PubMedGoogle Scholar
  25. 25.
    Peters M, Jansen E, ten Cate J, Kahlé LH, Ockelford P, Breederveld C (1984) Neonatal antithrombin III. Br J Haematol 58: 579–587PubMedCrossRefGoogle Scholar
  26. 26.
    Schmidt BK, Muraji T, Zipursky A (1986) Low antithrombin III in neonatal shock: DIC or non-specific protein depletion? Eur J Pediatr 145: 500–503PubMedCrossRefGoogle Scholar
  27. 27.
    Hathaway WE, Neumann LL, Borden CA, Jacobsen LJ (1978) Immunologic studies of antithrombin III heparin cofactor in the newborn. Thromb Haemost 39: 624–630PubMedGoogle Scholar
  28. 28.
    Henriksson P, Westström G, Hedner U (1979) Umbilical artery catheterization in newborns. Acta Paediatr Scand 68: 719–723PubMedGoogle Scholar
  29. 29.
    von Kries R, Schweickert M, Gunzelmann KH, Göbel U (1984) Antithrombin III activity and concentration in healthy and ill newborns. Lab Med 7: 353–357Google Scholar
  30. 30.
    Peters M, ten Cate JW, Breederveld C, de Leeuw R, Emeis J, Koppe J (1984) Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: Poor prognosis. Pediatr Res 18: 273–276PubMedCrossRefGoogle Scholar
  31. 31.
    Andrew M, Massicotté-Nolan P, Mitchell L, Cassidy K (1985) Dysfunctional antithrombin III in sick premature infants. Pediatr Res 19: 237–239PubMedCrossRefGoogle Scholar
  32. 32.
    Schander K, Niesen K, Rehm A, Budde U, Müller N (1980) Diagnosis and therapy of a congenital antithrombin III deficiency during the neonatal period. In: Deutsch E, Lechner K (eds) Fibrinolyse, Thrombose and Haemostase. Schattauer Verlag, Stuttgart, pp 483–486Google Scholar
  33. 33.
    Brenner B, Fishman A, Goldsher D, Schreibman D, Tavory S (1988) Cerebral thrombosis in a newborn with a congenital deficiency of antithrombin III. Am J Hematol 27: 209–221PubMedCrossRefGoogle Scholar
  34. 34.
    Markarian M (1982) Heparin resistance in newborn infants. J Pediatr 103: 175Google Scholar
  35. 35.
    von Kries R, Stannigel H, Göbel U (1985) Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 144: 191–194CrossRefGoogle Scholar
  36. 36.
    Ambrus CM, Choi TS, Cunnanan E, Eisenberg B, Staub HP, Weintraub H Q (1977) Prevention of hyaline membrane disease with plasminogen. A cooperative study. JAMA 237: 1837–1841PubMedCrossRefGoogle Scholar
  37. 37.
    Peters M, ten Cate JW, Jansen E, Breederveld C (1985) Coagulation and fibrinolytic factors in the first week of life in healthy infants. J Pediatr 106: 292–295PubMedCrossRefGoogle Scholar
  38. 38.
    Hadnagy J, Giertler U, Halvax L, Sulyok E, Ertl T, Csaba IF, Buchenan W (1983) The antithrombin Ill-activity in the newborn age. Dtsch Gesundh Wesen 38: 1719–1720Google Scholar

Copyright information

© Springer Japan 1991

Authors and Affiliations

  • Hermann Erich Karges
    • 1
  1. 1.Research Laboratories of BehringwerkeMarburg 1Federal Republic of Germany

Personalised recommendations